STAGE III BLADDER UROTHELIAL CARCINOMA AJCC V6 AND V7
Clinical trials for STAGE III BLADDER UROTHELIAL CARCINOMA AJCC V6 AND V7 explained in plain language.
Never miss a new study
Get alerted when new STAGE III BLADDER UROTHELIAL CARCINOMA AJCC V6 AND V7 trials appear
Sign up with your email to follow new studies for STAGE III BLADDER UROTHELIAL CARCINOMA AJCC V6 AND V7, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo tested before surgery for tough bladder cancers
Disease control OngoingThis early-stage study is testing the safety of a two-drug immunotherapy combination (durvalumab and tremelimumab) given before surgery to patients with aggressive bladder and related urinary tract cancers. The trial is specifically for patients who cannot receive the usual pre-s…
Matched conditions: STAGE III BLADDER UROTHELIAL CARCINOMA AJCC V6 AND V7
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 27, 2026 12:41 UTC
-
New pill targets genetic weakness in Tough-to-Treat bladder cancers
Disease control OngoingThis study is testing an oral drug called sapanisertib for people with advanced bladder cancer that has a specific genetic mutation (TSC1 or TSC2) and has stopped responding to standard platinum-based chemotherapy. The goal is to see if the drug can shrink tumors and control the …
Matched conditions: STAGE III BLADDER UROTHELIAL CARCINOMA AJCC V6 AND V7
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Major trial tests Immune-Boosting drug to stop aggressive bladder cancer from coming back
Disease control OngoingThis large study is testing whether a drug called pembrolizumab can help prevent cancer from returning in people who have had surgery for muscle-invasive bladder or upper urinary tract cancer. After surgery, participants are randomly assigned to either receive the drug (which hel…
Matched conditions: STAGE III BLADDER UROTHELIAL CARCINOMA AJCC V6 AND V7
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 25, 2026 14:08 UTC